Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes
- PMID: 11797012
- DOI: 10.1038/415335a
Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes
Abstract
Potent virus-specific cytotoxic T lymphocyte (CTL) responses elicited by candidate AIDS vaccines have recently been shown to control viral replication and prevent clinical disease progression after pathogenic viral challenges in rhesus monkeys. Here we show that viral escape from CTL recognition can result in the eventual failure of this partial immune protection. Viral mutations that escape from CTL recognition have been previously described in humans infected with human immunodeficiency virus (HIV) and monkeys infected with simian immunodeficiency virus (SIV). In a cohort of rhesus monkeys that were vaccinated and subsequently infected with a pathogenic hybrid simian-human immunodeficiency virus (SHIV), the frequency of viral sequence mutations within CTL epitopes correlated with the level of viral replication. A single nucleotide mutation within an immunodominant Gag CTL epitope in an animal with undetectable plasma viral RNA resulted in viral escape from CTLs, a burst of viral replication, clinical disease progression, and death from AIDS-related complications. These data indicate that viral escape from CTL recognition may be a major limitation of the CTL-based AIDS vaccines that are likely to be administered to large human populations over the next several years.
Comment in
-
One step forwards, one step back.Nature. 2002 Jan 17;415(6869):272-3. doi: 10.1038/415272b. Nature. 2002. PMID: 11796990 No abstract available.
Similar articles
-
Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model.Vaccine. 2001 Dec 12;20(5-6):813-25. doi: 10.1016/s0264-410x(01)00408-x. Vaccine. 2001. PMID: 11738745
-
Involvement of multiple epitope-specific cytotoxic T-lymphocyte responses in vaccine-based control of simian immunodeficiency virus replication in rhesus macaques.J Virol. 2006 Feb;80(4):1949-58. doi: 10.1128/JVI.80.4.1949-1958.2006. J Virol. 2006. PMID: 16439550 Free PMC article.
-
Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection.J Virol. 2000 Aug;74(16):7485-95. doi: 10.1128/jvi.74.16.7485-7495.2000. J Virol. 2000. PMID: 10906202 Free PMC article.
-
Cytotoxic T lymphocytes specific for the simian immunodeficiency virus.Immunol Rev. 1999 Aug;170:127-34. doi: 10.1111/j.1600-065x.1999.tb01334.x. Immunol Rev. 1999. PMID: 10566147 Review.
-
Understanding cytotoxic T-lymphocyte escape during simian immunodeficiency virus infection.Immunol Rev. 2001 Oct;183:115-26. doi: 10.1034/j.1600-065x.2001.1830110.x. Immunol Rev. 2001. PMID: 11782252 Review.
Cited by
-
Viral escape mutations do not account for non-protection from SIVmac239 challenge in RhCMV/SIV vaccinated rhesus macaques.Front Immunol. 2024 Aug 7;15:1444621. doi: 10.3389/fimmu.2024.1444621. eCollection 2024. Front Immunol. 2024. PMID: 39170621 Free PMC article.
-
CCR5∆32 and SDF1 3'A: Gene Variants, Expression and Influence on Biological Markers for the Clinical Progression to AIDS among HIV-1 Virus Controllers in a Mixed Population of the Amazon Region of Brazil.Int J Mol Sci. 2023 Mar 4;24(5):4958. doi: 10.3390/ijms24054958. Int J Mol Sci. 2023. PMID: 36902388 Free PMC article.
-
PD-1 blockade following ART interruption enhances control of pathogenic SIV in rhesus macaques.Proc Natl Acad Sci U S A. 2022 Aug 16;119(33):e2202148119. doi: 10.1073/pnas.2202148119. Epub 2022 Aug 8. Proc Natl Acad Sci U S A. 2022. PMID: 35939675 Free PMC article.
-
Characterization of CD8 T Cell-Mediated Mutations in the Immunodominant Epitope GP33-41 of Lymphocytic Choriomeningitis Virus.Front Immunol. 2021 Jun 14;12:638485. doi: 10.3389/fimmu.2021.638485. eCollection 2021. Front Immunol. 2021. PMID: 34194424 Free PMC article.
-
Mucosal IL-4R antagonist HIV vaccination with SOSIP-gp140 booster can induce high-quality cytotoxic CD4+/CD8+ T cells and humoral responses in macaques.Sci Rep. 2020 Dec 16;10(1):22077. doi: 10.1038/s41598-020-79172-7. Sci Rep. 2020. PMID: 33328567 Free PMC article.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
